JP2850086B2 - Exothermic substance adsorbent - Google Patents

Exothermic substance adsorbent

Info

Publication number
JP2850086B2
JP2850086B2 JP24847193A JP24847193A JP2850086B2 JP 2850086 B2 JP2850086 B2 JP 2850086B2 JP 24847193 A JP24847193 A JP 24847193A JP 24847193 A JP24847193 A JP 24847193A JP 2850086 B2 JP2850086 B2 JP 2850086B2
Authority
JP
Japan
Prior art keywords
solution
acid
adsorbent
exothermic substance
pyrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP24847193A
Other languages
Japanese (ja)
Other versions
JPH0780293A (en
Inventor
豊一 大川
健一 星
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BAIRETSUKUSU JUGEN
Original Assignee
BAIRETSUKUSU JUGEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BAIRETSUKUSU JUGEN filed Critical BAIRETSUKUSU JUGEN
Priority to JP24847193A priority Critical patent/JP2850086B2/en
Publication of JPH0780293A publication Critical patent/JPH0780293A/en
Application granted granted Critical
Publication of JP2850086B2 publication Critical patent/JP2850086B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、胆汁酸を有効成分とす
る発熱性物質の吸着剤に関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a pyrogen-containing adsorbent containing bile acid as an active ingredient.

【0002】[0002]

【従来の技術】発熱性物質(パイロジェン、Pyrog
en )は一般に細菌性のものであり、細菌毒素と称さ
れており外毒素(エキソトキシン、Exotoxin)
および内毒素(エンドトキシン、Endotoxin
)に大別されている。これらの毒素のうち、グラム陰
性菌の細胞壁燐脂質多糖体(リポポリサッカライド、L
ipopolysaccharide:LPS)を構成
する多糖(PS)およびリン脂質(リピドA、Lipi
d A)であることが確認され、発熱活性中心はリピド
Aであることが明らかになっている。従来、発熱性物質
の除去法としては物理的に吸着させる方法や化学的に分
解させる方法が知られており、このうち物理的吸着法に
おいては、主薬が分解されるおそれが少なく操作方法と
しても簡便であり、イオン交換体吸着法など用いられて
いる。しかしながら、これらの方法は吸着性能に問題が
あり完全に発熱性物質を除去することが困難である。ま
た、この発熱性物質はその耐熱性および化学的安定性の
ために製剤中に混入した場合の生理的条件下での除去、
不活化は極めて困難であった。
2. Description of the Related Art Pyrogenic substances (pyrogen, Pyrog)
en) is generally bacterial and is referred to as a bacterial toxin, and is an exotoxin (Exotoxin)
And endotoxin (Endotoxin, Endotoxin
). Among these toxins, cell wall phospholipid polysaccharides of gram-negative bacteria (lipopolysaccharide, L
Polysaccharides (PS) and phospholipids (lipid A, Lipi) constituting ipopolysaccharide (LPS)
dA), and it has been revealed that the exothermic active center is lipid A. Conventionally, as a method for removing the exothermic substance, a method of physically adsorbing or a method of chemically decomposing are known. Among them, in the physical adsorption method, there is little possibility that the main drug is decomposed, and even as an operation method, It is simple, and an ion exchanger adsorption method or the like is used. However, these methods have problems in adsorption performance, and it is difficult to completely remove exothermic substances. In addition, this pyrogen is removed under physiological conditions when mixed into the formulation due to its heat resistance and chemical stability,
Inactivation was extremely difficult.

【0003】[0003]

【発明が解決しようとする課題】本発明は、かかる状況
下に鑑み、発熱性物質の吸着除去に有用な技術を提供す
ることを目的としたものである。
SUMMARY OF THE INVENTION It is an object of the present invention to provide a technique useful for adsorbing and removing exothermic substances in view of such circumstances.

【0004】[0004]

【課題を解決するための手段】かかる課題を解決せんと
して、本願発明者らは生理的条件下での発熱性物質の除
去、不活化について検討した結果、以下の本発明を完成
した。
Means for Solving the Problems In order to solve such problems, the inventors of the present invention have studied the removal and inactivation of pyrogenic substances under physiological conditions, and as a result, have completed the present invention described below.

【0005】すなわち本発明は、固定化した胆汁酸から
成ることを特徴とする発熱性物質吸着剤に係るものであ
る。
[0005] That is, the present invention relates to an exothermic substance adsorbent comprising an immobilized bile acid.

【0006】本発明で使用される胆汁酸は、その構造か
ら以下のように類別される 1)モノヒドロキシコラン酸;例えば、リトコール酸 2)モノヒドロキシコレン酸;例えば、3βーヒドロキ
シーΔ5ーコレン酸 3)モノオキソコラン酸;例えば、3ーオキソー5βー
コラン酸 4)ジヒドロキシコラン酸;例えば、ウルソデオキシコ
ール酸、デオキシコール酸 5)モノヒドロキシモノオキソコラン酸;例えば,3α
ーヒドロキシー6ーオキソー5αーコラン酸 6)ジオキソコラン酸;例えば、3,12ージオキソー
5βーコラン酸 7)トリヒドロキシコラン酸;例えば、コール酸 8)ジヒドロキシモノオキソコラン酸;例えば、3α,
7αージヒドロキシー12ーオキソー5βーコラン酸 9)テトラヒドロキシコラン酸;例えば、3α,7α,
12α,23ーテトラオキシー5βーコラン酸 これらの類別した胆汁酸は、ステロイド化合物の一種で
あり炭素数24のコラン酸を基本骨格とし、そのコラン
酸のオキシ誘導体である。側鎖に1〜4個の水酸基もし
くはケト基をもっており多くは天然物であるが部分合成
もあり生体内で代謝、分解される。胆汁酸は、その中に
は医薬原料として利用されているものもあり、極めて安
全性が高い物質と言える。
The bile acids used in the present invention are classified according to their structures as follows: 1) monohydroxycholanoic acid; for example, lithocholic acid 2) monohydroxycholenic acid; for example, 3β-hydroxy-Δ 5 -cholenic acid 3 ) Monooxocholanic acid; for example, 3-oxo-5β-cholanic acid 4) dihydroxycholanic acid; for example, ursodeoxycholic acid, deoxycholic acid 5) monohydroxymonooxocholanic acid; for example, 3α
-Hydroxy-6-oxo-5α-cholanic acid 6) dioxocholanic acid; for example, 3,12-dioxo-5β-cholanic acid 7) trihydroxycholanic acid; for example, cholic acid 8) dihydroxymonooxocholanic acid; for example, 3α,
7α-dihydroxy-12-oxo-5β-cholanic acid 9) Tetrahydroxycholanic acid; for example, 3α, 7α,
12α, 23-Tetraoxy-5β-cholanoic acid These classified bile acids are a kind of steroid compounds, and have a basic skeleton of 24 carbon atoms of colanic acid, and are oxy derivatives of the colanic acid. It has 1 to 4 hydroxyl groups or keto groups on the side chain and is mostly a natural product, but is also partially synthesized and is metabolized and decomposed in vivo. Some bile acids are used as pharmaceutical raw materials and can be said to be extremely safe substances.

【0007】本発明の発熱性物質吸着剤は、胆汁酸と発
熱性物質との親和性を利用したもので、胆汁酸は、担体
に担持させ、固定化させる。このように胆汁酸を担体に
担持させ固定化させることにより、発熱性物質の吸着除
去に有用なものとなし得る。使用する担体としては、前
記胆汁酸を直接またはスペーサーを介して結合させるも
のであればいずれでもよい。かかる担体の代表的な例と
しては、水酸基、アミノ基、カルボキシル基またはハロ
ゲン原子を有する水不溶性担体が挙げられる。水不溶性
担体の選択およびリガンドである前記胆汁酸との結合方
法は特に限定されるものではなく、既存の方法で行うこ
とができる。本発明の吸着剤と発熱性物質含有溶液とを
接触させた後、当該吸着剤と溶液を分離させると、吸着
剤側に発熱性物質が良好に吸着され、発熱性物質を含ま
ない溶液を得ることができる。本発明の吸着剤を利用し
た発熱性物質含有溶液からの発熱性物質の吸着除去方法
の例としては、バッチ法およびカラム法が挙げられる。
前者は本発明の発熱性物質吸着剤と発熱性物質含有溶液
を混合し、ラウンドミキサーにより十分に撹拌した後、
発熱性物質吸着剤と溶液とを分離することにより、発熱
性物質を含まない溶液を得る方法であり、後者は本発明
の発熱性物質吸着剤をカラムに充填し発熱性物質含有溶
液を通過させることにより、発熱性物質を含まない溶液
を得る方法である。
[0007] The exothermic substance adsorbent of the present invention utilizes the affinity between bile acids and exothermic substances. Bile acids are supported on a carrier and immobilized. By supporting and immobilizing the bile acid on the carrier in this way, it can be useful for adsorption removal of pyrogenic substances. As the carrier to be used, any carrier may be used as long as the above-mentioned bile acid is bound directly or via a spacer. A typical example of such a carrier is a water-insoluble carrier having a hydroxyl group, an amino group, a carboxyl group, or a halogen atom. The method of selecting the water-insoluble carrier and the method of binding to the bile acid as a ligand are not particularly limited, and can be performed by an existing method. After the adsorbent of the present invention is brought into contact with the exothermic substance-containing solution, when the adsorbent and the solution are separated, the exothermic substance is favorably adsorbed on the adsorbent side to obtain a solution containing no exothermic substance. be able to. Examples of the method of removing and removing a pyrogenic substance from a pyrogenic substance-containing solution using the adsorbent of the present invention include a batch method and a column method.
The former is to mix the exothermic substance adsorbent of the present invention and the exothermic substance-containing solution, and sufficiently stirred by a round mixer,
This is a method of obtaining a solution containing no exothermic substance by separating the exothermic substance adsorbent and the solution.The latter is a method of filling the exothermic substance adsorbent of the present invention into a column and passing the exothermic substance-containing solution. This is a method for obtaining a solution containing no exothermic substance.

【0008】[0008]

【実施例】本発明を実施例に基づき具体的に説明する
が、本発明はこれによって何ら限定されるものではな
い。なお、実施例において用いた測定法は次の通りであ
る。 1.胆汁酸測定法 胆汁酸に補酵素NADと3αーヒドロキシステロイドデ
ヒドロゲーナーゼ(3αーHSD)を作用すると胆汁酸
の3α位の水酸基は特異的に酸化されて3ーケトステロ
イドとなり、同時にNADHとなる。生成したNADH
はジアホラーゼを介してニトロテトラゾリウムブルー
(NTB)を還元し、赤紫色のジホルマザンを生成す
る。この赤紫色の吸光度を測定することにより試料中の
総胆汁酸の含量を求める。(総胆汁酸ーテスト ワコ
ー:説明書より) [文献;真重文子、山中学:臨床化学、8,191(1
985)] 2.エンドトキシン比色定量法によるエンドトキシンの
測定法 測定試薬はToxicolor(生化学工業(株)社
製)を用いた。この試薬は発色合成基質及びカブトガニ
血球抽出液を岩永らの方法をもとに調製された。同法に
よってエンドトキシンの定量が可能である。(文献;大
林民典、他:臨床病理、33,639〜644,198
5)
EXAMPLES The present invention will be specifically described based on examples, but the present invention is not limited to these examples. The measuring method used in the examples is as follows. 1. Bile acid measurement method When the coenzyme NAD and 3α-hydroxysteroid dehydrogenase (3α-HSD) act on bile acid, the hydroxyl group at the 3α-position of bile acid is specifically oxidized to 3-ketosteroid and simultaneously to NADH. The generated NADH
Reduces nitrotetrazolium blue (NTB) via diaphorase to produce magenta diformazan. The content of total bile acids in the sample is determined by measuring the absorbance of the purple-red color. (Total bile acid-Test Wako: From the manual) [References: Fumiko Maeshi, Manabu Yamanaka: Clinical Chemistry, 8, 191 (1)
985)] 2. Method for measuring endotoxin by endotoxin colorimetric method Toxicolor (manufactured by Seikagaku Corporation) was used as a measuring reagent. This reagent was prepared from a chromogenic synthetic substrate and a horseshoe crab blood cell extract based on the method of Iwanaga et al. Endotoxin can be quantified by the same method. (Literature; Tamunori Obayashi et al .: Clinical Pathology, 33, 639-644, 198)
5)

【0009】製造例1 アミノーセルロファイン(多孔性の真球状セルロースを
エポキシ活性化後、アミノ化担体としたもの)をグラス
フィルター上でパイロジェンフリー水で十分洗浄し、ろ
過したアミノーセルロファイン(湿重量)1g当たり4
mgのウルソデオキシコール酸溶液(予め弱アルカリ溶
液で溶解しpH9に調整する)5mlと混合振盪し、室
温で2時間反応させた後、ジメチルアミノボラン(3.
5mgを含む溶液0.5ml)を振盪させながら加え、
4℃で18時間反応させた。担体と溶液を分離するため
グラスフィルター上でろ過をし、50mMリン酸緩衝液
(pH7.2)を使用して十分洗浄した。グラスフィル
ター上にはウルソデオキシコール酸をリガンド結合した
発熱性物質吸着剤を得た。本品のウルソデオキシコール
酸含量は、7.3μmole/g(湿重量)吸着剤であ
った。但し、生成物中のリガンド化合物の含量は、反応
前のリガンド化合物溶液と生成物の洗浄液(ろ液を含
む)の胆汁酸酵素比色法の差から求めた。以下同。
Production Example 1 Amino-Cellulofine (porous spherical cellulose which was activated by epoxy and then used as an aminated carrier) was sufficiently washed with pyrogen-free water on a glass filter and filtered. 4 per gram of wet weight)
After mixing and shaking with 5 ml of ursodeoxycholic acid solution (previously dissolved in a weak alkaline solution to adjust to pH 9) and reacting at room temperature for 2 hours, dimethylaminoborane (3.
0.5 mg of a solution containing 5 mg) with shaking,
The reaction was performed at 4 ° C. for 18 hours. The solution was filtered on a glass filter to separate the carrier and the solution, and sufficiently washed using a 50 mM phosphate buffer (pH 7.2). An exothermic substance adsorbent having ursodeoxycholic acid as a ligand was obtained on the glass filter. The ursodeoxycholic acid content of this product was 7.3 μmole / g (wet weight) adsorbent. However, the content of the ligand compound in the product was determined from the difference in the bile acid enzyme colorimetric method between the ligand compound solution before the reaction and the washing solution (including the filtrate) of the product. The same shall apply hereinafter.

【0010】実施例1 上記製造例1で調製した発熱性物質吸着剤20mlをパ
イロジェンフリーの1M(モル)食塩液100mlに分
散させカラムに充填し、0.1N/水酸化ナトリウム溶
液100mlを通過させ、更に、10mM酢酸ナトリウ
ム緩衝液(pH7.2)で平衡化する。次に、E.co
li UKTーB,コントロール881のLPSをパイ
ロジェンフリーの人由来アルブミン(生物学的製剤基準
での発熱試験では1羽当たりの体温上昇は0.2度以
下)をパイロジェンフリー水でアルブミン濃度を2%に
希釈し、前記LPSを370ng加え、100mlとし
た。この溶液を、準備した(発熱性物質吸着剤を緩衝液
で平行化)カラムに通過させ、アルブミン液を回収した
ところ、LPSは検出されなかった。更に、10mM酢
酸ナトリウム緩衝液(pH7.2)を通過させ吸着剤を
洗浄したが、回収した洗浄液もLPSは検出されず、次
に、1M食塩液をカラムに通過させ流出液を回収したと
ころ、LPSが369ng検出された。
Example 1 20 ml of the exothermic substance adsorbent prepared in Production Example 1 was dispersed in 100 ml of a pyrogen-free 1 M (molar) saline solution, filled in a column, and allowed to pass through 100 ml of a 0.1 N / sodium hydroxide solution. And then equilibrate with 10 mM sodium acetate buffer (pH 7.2). Next, E. co
li UKT-B, LPS of control 881 was replaced with pyrogen-free human-derived albumin (the body temperature rise per bird was 0.2 ° C or less in a fever test based on biologics) and the concentration of albumin in pyrogen-free water was 2%. And 370 ng of the LPS was added to make 100 ml. This solution was passed through a prepared column (parallelizing the exothermic substance adsorbent with a buffer solution), and the albumin solution was recovered. LPS was not detected. Further, the adsorbent was washed by passing through a 10 mM sodium acetate buffer solution (pH 7.2). However, LPS was not detected in the recovered washing solution. Next, 1 M saline solution was passed through the column to collect the effluent. LPS was detected at 369 ng.

【0011】製造例2 製造例1において、アミノーセルロファインの代わりに
EAHーセファロース4B(セファロースゲルをエポキ
シ活性化し1,6ージアミノヘキサンを共有結合させて
調製した担体)を用いる以外は、製造例1と同様に処理
する。本品のウルソデオキシコール酸含量は5.6μm
ole/g(湿重量)吸着剤であった。
Production Example 2 Production Example 1 is the same as Production Example 1, except that EAH-Sepharose 4B (a carrier prepared by epoxy-activating sepharose gel and covalently bonding 1,6-diaminohexane) is used instead of amino-cellulofine. The processing is performed in the same manner as 1. Ursodeoxycholic acid content of this product is 5.6 μm
ole / g (wet weight) adsorbent.

【0012】実施例2 製造例2で調製した発熱性物質吸着剤20mlをパイロ
ジェンフリーの1M(モル)食塩液100mlに分散さ
せカラムに充填し、0.1N/水酸化ナトリウム溶液1
00mlを通過させ、更に、5mM酢酸ナトリウム緩衝
液(pH7.2)で平衡化する。次に、E.coli
UKTーB,コントロール881のLPSをパイロジェ
ンフリーの人由来アルブミン(生成物学的製剤基準での
発熱試験では1羽当たりの体温上昇は0.2度以下)を
パイロジェンフリー水でアルブミン濃度を2%に希釈
し、前記LPSを430ng加え100mlとした。こ
の溶液を、準備した(発熱性物質吸着剤を緩衝液で平衡
化)カラムに通過させアルブミン液を回収したところ、
LPSは検出されなかった。更に、5mM酢酸ナトリウ
ム緩衝液(pH7.2)を通過させ吸着剤を洗浄した
が、回収した洗浄液もLPSは検出されず、次に、1M
食塩液をカラムに通過させ流出液を回収したところLP
Sが429.6ng検出された。
Example 2 20 ml of the exothermic substance adsorbent prepared in Production Example 2 was dispersed in 100 ml of a pyrogen-free 1 M (molar) saline solution, and the mixture was packed in a column.
And then equilibrate with 5 mM sodium acetate buffer (pH 7.2). Next, E. coli
UKT-B, LPS of control 881 was replaced with a pyrogen-free human-derived albumin (the body temperature rise per bird was 0.2 ° C or less in a fever test based on the product formulation) and 2% albumin concentration in pyrogen-free water. And 430 ng of the LPS was added to make 100 ml. This solution was passed through a prepared column (equilibrated with a pyrogen adsorbent with a buffer solution) to recover an albumin solution.
LPS was not detected. Further, the adsorbent was washed by passing through a 5 mM sodium acetate buffer (pH 7.2). However, LPS was not detected in the recovered washing solution.
When the saline solution was passed through the column and the effluent was collected, LP
429.6 ng of S was detected.

【0013】製造例3 製造例1においてウルソデオキシコール酸の代わりにコ
ール酸を用いる以外は製造例1と同様に処理した。本品
のコール酸含量は6.0μmole/g(湿重量)吸着
剤であった。
Production Example 3 The procedure of Production Example 1 was repeated except that cholic acid was used instead of ursodeoxycholic acid. The product had a cholic acid content of 6.0 μmole / g (wet weight) adsorbent.

【0014】実施例3 製造例3で調製した発熱性物質吸着剤25mlをパイロ
ジェンフリーの1M(モル)食塩液125mlに分散さ
せカラムに充填し、0.1N/水酸化ナトリウム溶液1
5mlを通過させ、更に、10mMリン酸緩衝液(pH
6.5)で平衡化する。次に、E.coli 055の
LPSをパイロジェンフリーの人由来アルブミン(生物
学的製剤基準での発熱試験では1羽当たりの体温上昇は
0.2度以下)をパイロジェンフリー水でアルブミン濃
度を2%に希釈し、前記LPSを85ng加え50ml
とした。この溶液を、準備した(発熱性物質吸着剤を緩
衝液で平衡化)カラムに通過させアルブミン液を回収し
たところ、LPSは90%吸着除去された。
Example 3 25 ml of the exothermic substance adsorbent prepared in Production Example 3 was dispersed in 125 ml of a pyrogen-free 1 M (molar) saline solution, and the mixture was packed in a column.
5 ml, and 10 mM phosphate buffer (pH
Equilibrate in 6.5). Next, E. E. coli 055 LPS was diluted with pyrogen-free human-derived albumin (the body temperature rise per bird was 0.2 ° C. or less in a fever test based on biological preparations) by diluting albumin concentration to 2% with pyrogen-free water. Add 85ng LPS and 50ml
And This solution was passed through a prepared column (equilibrated with a pyrogen adsorbent with a buffer solution) to recover an albumin solution. As a result, 90% of LPS was adsorbed and removed.

【0015】実施例4 製造例2で調製した発熱性物質吸着剤1mlをパイロジ
ェンフリーの1M(モル)食塩液5mlに分散させカラ
ムに充填し、0.1N/水酸化ナトリウム溶液15ml
を通過させ、更に、10mMリン酸緩衝液(pH7.
0)で平衡化する。次に、各種の菌に由来する発熱性物
質(LPS)を含む10mMリン酸バッファー水溶液
(pH7.0)をカラム(発熱性物質吸着剤を緩衝液で
平衡化した)に通過させ、発熱性物質が検出されるまで
流下する。さらに10mM緩衝液(pH7.0)を流下
させ発熱性物質が検出されなくなるまで洗浄流下させ
る。吸着された発熱性物質を発熱性物質吸着剤から溶出
させるため1M食塩液を流下し溶液を回収し発熱性物質
量を測定した。その結果を表1に示す。
Example 4 1 ml of the exothermic substance adsorbent prepared in Production Example 2 was dispersed in 5 ml of a pyrogen-free 1 M (molar) saline solution and packed in a column, followed by 15 ml of a 0.1 N / sodium hydroxide solution.
And further pass through a 10 mM phosphate buffer (pH 7.
Equilibrate in 0). Next, a 10 mM phosphate buffer aqueous solution (pH 7.0) containing a pyrogen (LPS) derived from various bacteria was passed through a column (a pyrogen-adsorbent was equilibrated with a buffer), and the pyrogen was added. Flow down until is detected. Further, a 10 mM buffer solution (pH 7.0) is allowed to flow down, and washing is performed until no pyrogenic substance is detected. In order to elute the adsorbed exothermic substance from the exothermic substance adsorbent, a 1 M saline solution was allowed to flow down, the solution was recovered, and the amount of the exothermic substance was measured. Table 1 shows the results.

【0016】[0016]

【表1】 [Table 1]

【0017】実施例5.製造例2で調製した発熱性物質
吸着剤1mlをパイロジェンフリーの1M(モル)食塩
液5mlに分散させカラムに充填し、0.1N/水酸化
ナトリウム溶液15mlを通過させ、更に、5mMリン
酸緩衝液(pH7.0)で平衡化する。次に、各種の菌
に由来する発熱性物質(LPS)を含む5mMリン酸バ
ッファー水溶液(pH7.0)をカラム(発熱性物質吸
着剤を緩衝液で平衡化した)に通過させ、発熱性物質が
検出されるまで流下する。更に、5mMリン酸緩衝液
(pH7.0)を流下させ発熱性物質が検出されなくな
るまで洗浄流下させる。吸着された発熱性物質を発熱性
物質吸着剤から溶出させるため1M食塩液を流下し溶液
を回収し発熱性物質量を測定した。その結果を表2に示
す。
Embodiment 5 FIG. 1 ml of the exothermic substance adsorbent prepared in Production Example 2 was dispersed in 5 ml of a pyrogen-free 1 M (molar) saline solution, packed in a column, passed through 15 ml of a 0.1 N / sodium hydroxide solution, and further subjected to 5 mM phosphate buffer. Equilibrate with liquid (pH 7.0). Next, a 5 mM phosphate buffer aqueous solution (pH 7.0) containing a pyrogen (LPS) derived from various bacteria was passed through a column (a pyrogen-adsorbent was equilibrated with a buffer), and the pyrogen was added. Flow down until is detected. Further, a 5 mM phosphate buffer solution (pH 7.0) is allowed to flow down and the washing is caused to flow down until no pyrogenic substance is detected. In order to elute the adsorbed exothermic substance from the exothermic substance adsorbent, a 1 M saline solution was allowed to flow down, the solution was recovered, and the amount of the exothermic substance was measured. Table 2 shows the results.

【0018】[0018]

【表2】 [Table 2]

【0019】[0019]

【発明の効果】以上、本発明によれば、発熱性物質の吸
着除去に有用な技術を提供することができ、従来の発熱
性物質の除去法としての物理的吸着方法や化学的分解方
法では、吸着性能に問題があり完全に発熱性物質を除去
することが困難で、また、この発熱性物質はその耐熱性
および化学的安定性のために製剤中に混入した場合の生
理的条件下での除去、不活化が極めて困難であったが、
本発明では、これら諸問題を解決することができた。
As described above, according to the present invention, it is possible to provide a technique useful for removing and adsorbing exothermic substances, and it is difficult to use a conventional physical adsorption method or a chemical decomposition method as a method for removing exothermic substances. It is difficult to completely remove pyrogens due to problems in adsorption performance, and the pyrogens may be mixed under physiological conditions when mixed in the preparation due to their heat resistance and chemical stability. Removal and inactivation was extremely difficult,
The present invention has solved these problems.

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】固定化した胆汁酸から成ることを特徴とす
る発熱性物質吸着剤。
1. An exothermic substance adsorbent comprising an immobilized bile acid.
【請求項2】胆汁酸を水酸基、アミノ基、カルボキシル
基またはハロゲン原子を有する水不溶性担体に担持させ
て成る、請求項1に記載の発熱性物質吸着剤。
2. The exothermic substance adsorbent according to claim 1, wherein the bile acid is supported on a water-insoluble carrier having a hydroxyl group, an amino group, a carboxyl group or a halogen atom.
JP24847193A 1993-09-10 1993-09-10 Exothermic substance adsorbent Expired - Fee Related JP2850086B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP24847193A JP2850086B2 (en) 1993-09-10 1993-09-10 Exothermic substance adsorbent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24847193A JP2850086B2 (en) 1993-09-10 1993-09-10 Exothermic substance adsorbent

Publications (2)

Publication Number Publication Date
JPH0780293A JPH0780293A (en) 1995-03-28
JP2850086B2 true JP2850086B2 (en) 1999-01-27

Family

ID=17178646

Family Applications (1)

Application Number Title Priority Date Filing Date
JP24847193A Expired - Fee Related JP2850086B2 (en) 1993-09-10 1993-09-10 Exothermic substance adsorbent

Country Status (1)

Country Link
JP (1) JP2850086B2 (en)

Also Published As

Publication number Publication date
JPH0780293A (en) 1995-03-28

Similar Documents

Publication Publication Date Title
Skipski [47] Thin-layer chromatography of neutral glycosphingolipids
AUSTIN et al. Metachromatic form of diffuse cerebral sclerosis: VI. A rapid test for the sulfatase A deficiency in metachromatic leukodystrophy (MLD) urine
KR100209072B1 (en) Method of preparing biologically active reagents from succinmide containing polymers, analytical element and methods of use
JP2983015B2 (en) Sugar remover
Kimelberg et al. Interactions of cytochrome c with phospholipid membranes: Binding of cytochrome c to phospholipid liquid crystals
JPS644621B2 (en)
EP0001223A2 (en) Latex coated with a polyhydroxy compound, process for the preparation of this latex, immunological reagent containing this latex, process for the preparation of this reagent, application of this reagent, testing procedure utilising this reagent and reagent kit containing this reagent
Winecker et al. Detection of cocaine and its metabolites in amniotic fluid and umbilical cord tissue
JPH066073B2 (en) Compositions and methods for measuring peroxidase-like activity of hemoglobin
WO1988000702A1 (en) Cancer screening test
JP2850086B2 (en) Exothermic substance adsorbent
JP2001503863A (en) Protein extraction method
Mortensen et al. Medium-chain triglyceride medication as a pitfall in the diagnosis of non-ketotic C6-C10-dicarboxylic acidurias
Smith et al. Improved enzymatic assay of chloramphenicol.
JP2002277473A (en) Method and reagent for screening prediabetes state
WO2022155991A1 (en) Kit for detecting purine substances and application thereof
Munro et al. Effects of external osmolarity on phospholipid metabolism in Escherichia coli B
HARAUCHI et al. A method for determining urinary enzyme activities as nephrotoxic indicators in rats
Nielsen et al. On the pathogenetic role of prostaglandins in Bartter's syndrome.
JP2766869B2 (en) Determination of lower carboxylic acids in body fluid materials
JP2589079B2 (en) Method for producing purified guaiac fat
JPS6311628B2 (en)
CN113403300B (en) Method for enriching circulating free nucleic acid in body fluid by using MOF material and application thereof
Seidel et al. An improved and simple micro-method of sphingomyelinase assay in leukocytes and urine
Schultz et al. Studies on the distribution and concentration of thiamine in blood and urine

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees